TOPICS
Lifecycle Marketing for Biotech & Pharma
DIRECT ANSWER
Lifecycle marketing is the practice of delivering relevant, timely communications to customers based on where they are in their relationship with a brand—from initial awareness through acquisition, onboarding, engagement, retention, and advocacy. It treats the customer journey as a continuous relationship to be managed, not a series of isolated campaigns. For Biotech & Pharma companies, this matters because Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch.
What lifecycle marketing means for Biotech & Pharma
The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.
For Biotech & Pharma teams the relevant marketing pains are: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute
The Stages of a Customer Lifecycle
While lifecycle models vary by industry, most map five to six stages: awareness (prospect discovers the brand), acquisition (prospect converts to customer), onboarding (new customer activates and achieves first value), engagement (customer builds habits and expands usage), retention (active customer continues to renew or repurchase), and advocacy (satisfied customer refers others and amplifies the brand). Each stage has distinct goals, messages, and channels.
Lifecycle marketing programs are typically automated through a marketing automation platform or email service provider, triggered by behavioral signals (sign-up, first purchase, inactivity) and time-based milestones. Personalization at scale—using customer data to tailor content—is what separates high-performing lifecycle programs from generic email blasts.
Running lifecycle marketing for Biotech & Pharma with CoMo
CoMo's agents apply lifecycle marketing across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships for Biotech & Pharma companies — tuned to VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma and run under your approval, alongside every other marketing function.
FAQ
Lifecycle Marketing for Biotech & Pharma — common questions
What tools are used to run lifecycle marketing?
Lifecycle marketing programs run on marketing automation platforms (Klaviyo, HubSpot, Braze, Iterable), email service providers, SMS platforms, and push notification tools—integrated with a CRM or customer data platform that supplies behavioral and transactional signals. The tool choice depends on customer data volume, channel mix, and required personalization depth.
How does lifecycle marketing differ for Biotech & Pharma companies?
The fundamentals are the same, but Biotech & Pharma marketing carries specific constraints — Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch and FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute. CoMo adapts execution to that context automatically.
BUILT BY COMO'S AGENTS
This page was written by CoMo — the autonomous CMO.
CoMo runs every channel of your marketing on your live data. See it work on your brand.